These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6358630)

  • 1. [Effectiveness of obsidan in patients with ischemic heart disease and its effect on myocardial perfusion].
    Samoĭlenko LE; Grigor'iants RA; Kramer AA; Spizhovyĭ VN
    Kardiologiia; 1983 Sep; 23(9):81-4. PubMed ID: 6358630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in myocardial perfusion in ischemic heart disease as affected by nitrong].
    Kramer AA; Gasilin VS; Samoĭlenko LE
    Kardiologiia; 1980 Nov; 20(11):76-9. PubMed ID: 6777575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ischaemic heart disease with beta-adrenoblocking agents Trimepranol and Obsidan.
    Gasilin VS; Grigoriants RA; Lupanov VP; Lobova NM
    Cor Vasa; 1983; 25(1):10-6. PubMed ID: 6133699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD; Bogatyrev IV; Uchaĭkina LV; Syrkin AL
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of some antianginal drugs on the myocardial perfusion in patients with ischaemic heart disease.
    Gasilin VS; Kramer AA; Samoilenko LE
    Cor Vasa; 1981; 23(6):429-38. PubMed ID: 6800695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of obsidan on hemodynamic indices and clinical manifestations of angina pectoris in patients with ischemic heart disease during psychoemotional stress].
    Revenko VN; Bezu GG; Grib LF
    Kardiologiia; 1991 Feb; 31(2):27-9. PubMed ID: 2041284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous obsidan-induced changes of coronary venous blood flow in patients with coronary heart disease in the presence of transient myocardial ischemia].
    Uchaĭkina LV; Vakhlĭaev VD
    Kardiologiia; 1992 Feb; 32(2):17-21. PubMed ID: 1527928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic and treatment characteristics of ischemic heart disease patients with asynergies].
    Furkalo NK; Lutaĭ MI; Zaĭtseva VI
    Ter Arkh; 1985; 57(9):34-7. PubMed ID: 4082046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Several indices of hemodynamics, gas exchange and exercise tolerance during treatment of ischemic heart disease with obsidan].
    Ianovskiĭ GV; Girina NI; Slipchenko SG; Kuklia IuI
    Kardiologiia; 1976 Dec; 16(12):62-6. PubMed ID: 1011483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease].
    At'kov OIu; Krol VA; Chumburidze VB
    Ter Arkh; 1977; 49(10):57-60. PubMed ID: 22937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of anti-angina agents on ischemic heart muscles].
    Abiko Y
    Hokkaido Igaku Zasshi; 1976 Jan; 51(1):1-3. PubMed ID: 820619
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
    Kostin VI; Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the management of myocardial ischemia. Overview.
    Abrams J
    Am Heart J; 1990 Sep; 120(3):719-21; discussion 743-5. PubMed ID: 2389716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
    Motz W; Scheler S; Strauer BE
    Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of myocardial ischemia.
    Gorlin R
    Major Probl Intern Med; 1976; 11():232-62. PubMed ID: 10490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of the anti-anginal effect of obzidan].
    Furkalo NK; Zaĭtseva VI
    Kardiologiia; 1984 Jun; 24(6):73-6. PubMed ID: 6748496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional reserves of myocardial perfusion in patients with chronic ischemic heart disease with varying degrees of damage of the coronary arteries].
    Eventov AZ; Pisareva NA; Matveeva LS; Krol VA; Maevskaia EG
    Kardiologiia; 1986 May; 26(5):45-9. PubMed ID: 3735917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of obzidan efficacy in patients with unstable stenocardia].
    Gvatua NA; SHumakov VA; Tashchuk VK; Malinovskaia IE; Pliska AI
    Ter Arkh; 1989; 61(8):21-4. PubMed ID: 2588162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.